Pressure Biosciences Inc financial data

Symbol
PBIO on OTC
Industry
Laboratory Analytical Instruments
Location
480 Neponset St., Canton, MA
State of incorporation
MA
Fiscal year end
December 31
Former names
BOSTON BIOMEDICA INC (to 9/2/2004)
Latest financial report
10-Q - Q1 2024 - Sep 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.81 % -46%
Quick Ratio 1.43 % -54.3%
Debt-to-equity -109 % -0.87%
Return On Equity 25.9 % -57.7%
Return On Assets -285 % +62%
Operating Margin -381 % -55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.4M shares +72%
Common Stock, Shares, Outstanding 47.1M shares +161%
Entity Public Float 8M USD
Common Stock, Value, Issued 471K USD +161%
Weighted Average Number of Shares Outstanding, Basic 39.8M shares +151%
Weighted Average Number of Shares Outstanding, Diluted 39.8M shares +151%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2M USD +10.6%
Revenue from Contract with Customer, Excluding Assessed Tax 1.59M USD -20.3%
Research and Development Expense 1.2M USD +7.12%
Selling and Marketing Expense 635K USD +13.2%
General and Administrative Expense 6.05M USD +6.12%
Costs and Expenses 8.94M USD -5.33%
Operating Income (Loss) -7.35M USD +1.34%
Nonoperating Income (Expense) -23.2M USD -106%
Net Income (Loss) Attributable to Parent -8.07M USD +56.8%
Earnings Per Share, Basic -1.27 USD/shares +20.1%
Earnings Per Share, Diluted -1.27 USD/shares +52.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.22K USD -98.7%
Accounts Receivable, after Allowance for Credit Loss, Current 145K USD -63.1%
Inventory, Net 597K USD -10.4%
Assets, Current 957K USD -38.4%
Property, Plant and Equipment, Net 78.5K USD -21.4%
Operating Lease, Right-of-Use Asset 565K USD +195%
Intangible Assets, Net (Excluding Goodwill) 252K USD -30%
Goodwill 4.73M USD
Assets 6.99M USD +216%
Accounts Payable, Current 2.44M USD +217%
Employee-related Liabilities, Current 177K USD -33.9%
Liabilities, Current 44.6M USD +29.6%
Operating Lease, Liability, Noncurrent 380K USD +322%
Liabilities 45.1M USD +30.2%
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value 100 USD -90.9%
Retained Earnings (Accumulated Deficit) -178M USD -26%
Stockholders' Equity Attributable to Parent -38.1M USD -17.5%
Liabilities and Equity 6.99M USD +216%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.86M USD -340%
Net Cash Provided by (Used in) Financing Activities 1.78M USD +170%
Net Cash Provided by (Used in) Investing Activities -3K USD -164%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 47.1M shares +161%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -78.1K USD -133%
Interest Paid, Excluding Capitalized Interest, Operating Activities 325K USD -39.3%
Deferred Tax Assets, Valuation Allowance 40.6M USD +25.3%
Operating Lease, Liability 585K USD +277%
Payments to Acquire Property, Plant, and Equipment 3K USD +164%
Lessee, Operating Lease, Liability, to be Paid 960K USD +189%
Property, Plant and Equipment, Gross 655K USD +1.16%
Operating Lease, Liability, Current 205K USD +215%
Lessee, Operating Lease, Liability, to be Paid, Year Two 204K USD +204%
Lessee, Operating Lease, Liability, to be Paid, Year One 212K USD +229%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 375K USD +112%
Lessee, Operating Lease, Liability, to be Paid, Year Three 158K USD +205%
Deferred Tax Assets, Operating Loss Carryforwards 36.3M USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 164K USD
Operating Lease, Payments 48.6K USD -46.2%
Additional Paid in Capital 103M USD +35.4%
Share-based Payment Arrangement, Expense 240K USD -83.2%
Interest Expense 15.6M USD +49.3%